Junee Limited Announces Completion of Corporate Name Change to SuperX AI Technology Limited and Commencement of Trading Under New Ticker Symbol "SUPX" — Neutral
JUNE PRNewsWire — June 02, 2025SINGAPORE , June 2, 2025 /PRNewswire/ -- NASDAQ-listed company Junee Limited (NASDAQ: JUNE) today announced that it has completed its previously announced corporate name change and re-branding to SuperX AI Technology Limited ("SuperX" or the "Company"). In connection with the name change, the Company's ordinary shares will begin trading today on the Nasdaq Capital Market under the new ticker symbol "SUPX.

IBTA Investors Have Opportunity to Lead Ibotta, Inc. Securities Fraud Lawsuit with the Schall Law Firm — Neutral
IBTA PRNewsWire — June 02, 2025LOS ANGELES , June 2, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Ibotta, Inc. ("Ibotta" or "the Company") (NYSE: IBTA) for violations of the federal securities laws. Investors who purchased the Company's securities pursuant and/or traceable to the Company's Offering Documents issued in connection with its initial public offering ("IPO") conducted on April 18, 2024, are encouraged to contact the firm before June 16, 2025.

BBAI Investors with Losses of $100,000 Have Opportunity to Lead BigBear.ai Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm — Neutral
BBAI PRNewsWire — June 02, 2025LOS ANGELES , June 2, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against BigBear.ai Holdings, Inc. ("BigBear" or "the Company") (NYSE: BBAI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between March 31, 2022 and March 25, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before June 10, 2025.

Natural Gas Prices Tick Up Despite Another Triple-Digit Build — Negative
AR EXE GPOR Zacks Investment Research — June 02, 2025While natural gas remains under pressure, investors should continue keeping an eye on stocks such as EXE, GPOR and AR.

VTRS Investors Have Opportunity to Lead Viatris Inc. Securities Fraud Lawsuit with the Schall Law Firm — Neutral
VTRS PRNewsWire — June 02, 2025LOS ANGELES , June 2, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Viatris Inc. ("Viatris" or "the Company") (NASDAQ: VTRS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between August 8, 2024 and February 26, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before June 3, 2025.

Securities Lawsuit Alert: BigBear.ai Holdings, Inc. (BBAI) Investors - Contact Levi & Korsinsky Before June 10, 2025 — Neutral
BBAI Accesswire — June 02, 2025NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your BigBear.ai Holdings, Inc. (NYSE:BBAI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/bigbear-ai-holdings-inc-lawsuit-submission-form?prid=151251&wire=1&utm_campaign=2 or contact Joseph E. Levi, Esq.

Levi & Korsinsky Urges Zenas BioPharma, Inc. (ZBIO) Shareholders to Act Before Lead Plaintiff Deadline June 16, 2025 — Neutral
ZBIO Accesswire — June 02, 2025NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your Zenas BioPharma, Inc. (NASDAQ:ZBIO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/zenas-biopharma-inc-lawsuit-submission-form?prid=151250&wire=1&utm_campaign=18 or contact Joseph E. Levi, Esq.

New Synchrony Study Finds Nearly 8 out of 10 Pet Owners Underestimate the Cost of Care, Reaching Up to $61,000 During a Pet's Lifetime — Neutral
SYF PRNewsWire — June 02, 2025Lifetime of Care Costs Continue to Rise From 2022 Findings — Up More Than 10% For Dogs and Nearly 20% For Cats 2025 Study Adds Data on Small Companion Animals, Also Called "Pocket Pets" STAMFORD, Conn. , June 2, 2025 /PRNewswire/ -- Synchrony's (NYSE: SYF) new 2025 Pet Lifetime of Care Study reveals nearly 8 out of 10 pet owners underestimate the cost to care for their pet over a lifetime.

Fidelity Disruptors ETF: Example Why I Avoid Fund-Of-Funds — Neutral
FDIF Seeking Alpha — June 02, 2025FDIF offers exposure to all five Fidelity Disruptive ETFs, making it suitable for investors who don't want to pick individual winners. The fund has underperformed broad market benchmarks and most underlying ETFs, raising concerns about its effectiveness as a core holding. FDIF only makes sense for those seeking convenience, as it doesn't deliver superior returns or risk-adjusted performance compared to broad index funds.

PureCars Joins Toyota & Lexus Canada Programs as an Approved Provider for Digital Advertising — Neutral
TM GlobeNewsWire — June 02, 2025ATLANTA, June 02, 2025 (GLOBE NEWSWIRE) -- PureCars, the leading provider of digital advertising and marketing technology solutions for dealerships, is proud to announce its inclusion in the Toyota & Lexus Canada Programs as an approved provider of Digital Advertising. These partnerships enable PureCars to support Toyota & Lexus Canada dealers with a comprehensive suite of advertising solutions designed to drive measurable results and enhance customer engagement.

Lazard Asset Management Appoints Eric Van Nostrand Global Head of Markets and Chief Economist — Neutral
LAZ Business Wire — June 02, 2025NEW YORK--(BUSINESS WIRE)--Lazard Asset Management (LAM) today announced that Eric Van Nostrand has joined the firm as Global Head of Markets and Chief Economist. In this newly created role reporting to LAM CEO Evan Russo, Mr. Van Nostrand will work across the firm's investment and research teams, bringing additional macro insights and market perspectives to our investment decisions. As a member of the executive leadership team for Lazard's Asset Management business, he will lead economic and m.

Colgate-Palmolive Webcasts Fireside Chat at the Fifth Annual Evercore ISI Consumer and Retail Conference — Neutral
CL Business Wire — June 02, 2025NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive (NYSE:CL) President, Latin America, Juan Pablo Zamorano and Chief Investor Relations Officer and EVP, M&A, John Faucher will participate in a fireside chat at the Fifth Annual Evercore ISI Consumer and Retail Conference on Tuesday, June 10, 2025 at 1:00 p.m. ET. Investors may access a live webcast of this fireside chat on Colgate's website at www.colgatepalmolive.com. For those unable to participate during the live webcast, a recorded version of.

CGC Investors Have Opportunity to Lead Canopy Growth Corporation Securities Fraud Lawsuit with the Schall Law Firm — Neutral
CGC PRNewsWire — June 02, 2025LOS ANGELES , June 2, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Canopy Growth Corporation ("Canopy Growth" or "the Company") (NASDAQ: CGC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between May 30, 2024 and February 6, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before June 3, 2025.

MiNK Therapeutics Awarded Prestigious NIAID Grant to Advance Allo-iNKT Cell Therapy for Prevention of GvHD in Stem Cell Transplant Patients — Neutral
INKT GlobeNewsWire — June 02, 2025Non-dilutive NIH funding supports development of MiNK's allogeneic iNKT platform for immune regulation in high-risk HSCT settings Non-dilutive NIH funding supports development of MiNK's allogeneic iNKT platform for immune regulation in high-risk HSCT settings

The Journal of Clinical Oncology Publishes Five-year Analysis of Amtagvi® (lifileucel) in Patients with Advanced Melanoma — Neutral
IOVA GlobeNewsWire — June 02, 2025One-time Amtagvi Treatment Continues to Show Deep, Durable Responses and Meaningful Survival One Third of Responses Remain Ongoing without Subsequent Treatment after Five Years Simultaneous Presentation at ASCO 2025 SAN CARLOS, Calif., June 02, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today announced that the Journal of Clinical Oncology has published the final analysis from the Phase 2 C-144-01 clinical trial evaluating the individualized T cell therapy Amtagvi® (lifileucel) in patients with advanced melanoma.

RH stock is risky due to high debt and cyclical exposure, but offers potential upside if management executes expansion plans well. The company faces macroeconomic headwinds, especially from interest rates and housing market weakness, yet expects 10-13% revenue growth through innovation and expansion. RH's valuation appears attractive at 10x forward PE, with potential for 10% CAGR if management delivers and the economic environment improves.

ATHENS, Greece, June 02, 2025 (GLOBE NEWSWIRE) -- OceanPal Inc. (NASDAQ: OP) (the “Company”), a global shipping company specializing in the ownership of vessels, today announced that, through a separate wholly-owned subsidiary, it has signed a Memorandum of Agreement to sell the 2004-built dry bulk vessel “Protefs” to a third party, for a sale price of US$7 million before commissions with delivery to the buyer no later than June 17, 2025.

David P. Della Camera Becomes CFO of First Interstate BancSystem, Inc. — Neutral
FIBK Business Wire — June 02, 2025BILLINGS, Mont.--(BUSINESS WIRE)--First Interstate BancSystem, Inc. (NASDAQ: FIBK) (“First Interstate” or the “Company”) announced that effective June 1, 2025, David P. Della Camera has succeeded Marcy D. Mutch as the Company's Executive Vice President and Chief Financial Officer (CFO). This transition completes the Company's previously announced CFO succession plan, which was announced in February 2025. Mr. Della Camera joined First Interstate in 2021 and has held a range of senior finance lea.

Oilfield equipment maker Cactus to buy controlling interest in Baker Hughes' unit — Positive
BKR Reuters — June 02, 2025Oilfield equipment maker Cactus said on Monday it would purchase a 65% interest in Baker Hughes' surface pressure control business for $344.5 million.

Estrella MediaCo Announces Key Leadership Promotions in National and Digital Sales — Neutral
MDIA Business Wire — June 02, 2025NEW YORK--(BUSINESS WIRE)--Estrella MediaCo is pleased to announce the promotions of two standout leaders as part of its continued investment in cross-platform growth and multicultural market leadership. Rogerio Alves has been promoted to Vice President, Digital Sales – CTV and Audio Streaming, where he will lead monetization strategies across Estrella's growing digital video and audio portfolio, including FAST channels, CTV, and streaming audio platforms. “Rogerio has been instrumental in shap.
